tirzepatide approval obesity FDA for Zepbound (tirzepatide) injection, the first and only treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly BioCentury - Nov. 8 Quick

Helps eliminate free radicals and boosts immunity

The extract is meticulously standardized to contain between 65% and 75% procyanidins, which are complex biopolymers composed of catechin and epicatechin molecules

It effectively removes pigmentation, tan, and uneven spots while reducing wrinkles for a youthful, glowing complexion

It is a unimolecular formulation based on the GIP structure, with structural modifications to the peptide chain that enable interaction with both GLP-1 and GIP receptors.39 Its biological action on the GIP receptor is five times greater than that on the GLP-1 receptor.39 Effects on weight loss, body composition and diabetes prevention The SURMOUNT programme shows that TZP reduces weight in a dose-dependent manner, achieving a 22.5% weight reduction at the maximum weekly dose of 15 mg40 (Table 1)